✦ LIBER ✦

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: A success story with room for improvement

✍ Scribed by Sven Brandau; Henrik Suttmann

Book ID: 116313848
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 224 KB
Volume: 61
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2007.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

521 VPM1002 – a recombinant BCG with fav

521 VPM1002 – a recombinant BCG with favourable preclinical toxicity and immunogenicity for potential improvement of BCG immunotherapy for non-muscle invasive bladder cancer

✍ Rentsch, C.A.; Wetterauer, C.; Gsponer, J.R.; Püschel, H.; Bachmann, A.; De Blok 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

N40 DISCONTINUANCE OF BCG IMMUNOTHERAPY

N40 DISCONTINUANCE OF BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER IS ASSOCIATED WITH LOWER PROGRESSION FREE SURVIVAL

✍ A. Minich; O.G. Sukonko; S.A. Krasny; S.L. Polyakov; A.I. Rolevich; V.Y. Vasilev 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 590 KB

Intravesical BCG therapy for non-muscle-

Intravesical BCG therapy for non-muscle-invasive bladder cancer: Effect of concurrent statin therapy

✍ Ted A. Skolarus; Eugene Lee; Adam S. Kibel; M'Liss A. Hudson; Katherine S. Virgo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

DISCONTINUANCE OF BCG INSTILLATION THERA

DISCONTINUANCE OF BCG INSTILLATION THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER HAS A NEGATIVE IMPACT ON TUMOR RECURRENCE

✍ Takeda, Toshikazu; Kikuchi, Eiji; Yuge, Kazuyuki; Matsumoto, Kazuhiro; Miyajima, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB

A comparison of two BCG instillation reg

A comparison of two BCG instillation regimens for non-muscle invasive bladder cancer: A retrospective cohort analysis of side effect profiles

✍ J.R.F. Wilson; B.W. Turney; K. LeMonnier; J.P. Crew 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 300 KB

MP39-08 A LISTERIOLYSIN EXPRESSING BCG W

MP39-08 A LISTERIOLYSIN EXPRESSING BCG WITH FAVOURABLE IMMUNOGENICITY AND PRECLINICAL TOXICITY AS A NOVEL TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ Rentsch, Cyrill; Wetterauer, Christian; Gsponer, Joel; Püschel, Heike; Bachmann, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 185 KB